Chemerin has a protective role in hepatocellular carcinoma by inhibiting the expression of IL-6 and GM-CSF and MDSC accumulation

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Oncogene

• Publication date

  2017-02-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/onc.2016.516PMID 28166197
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of tumor metastasis by myeloid-derived suppressor cells.

  2015cited by this paper
• The yin and yang of evasion and immune activation in HCC.

  2015cited by this paper
• IL-6-stimulated CD11b+CD14+HLA-DR− myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus

  2014cited by this paper
• The E3 ubiquitin ligase Pellino3 protects against obesity-induced inflammation and insulin resistance.

  2014cited by this paper
• Chemerin suppresses murine allergic asthma by inhibiting CCL2 production and subsequent airway recruitment of inflammatory dendritic cells

  2014cited by this paper
• A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis.

  2014cited by this paper
• Chemerin aggravates DSS-induced colitis by suppressing M2 macrophage polarization

  2014cited by this paper
• The two faces of IL-6 in the tumor microenvironment.

  2014cited by this paper
• Impact of Serum Chemerin Levels on Liver Functional Reserves and Platelet Counts in Patients with Hepatocellular Carcinoma

  2014cited by this paper
• Natural killer cells in liver disease

  2013cited by this paper
• Increase in CD14+HLA-DR−/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis

  2013cited by this paper
• Expression, Regulation, and Function of Atypical Chemerin Receptor CCRL2 on Endothelial Cells

  2012cited by this paper
• The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defenses

  2012cited by this paper
• Adiponectin upregulates hepatocyte CMKLR1 which is reduced in human fatty liver.

  2012cited by this paper
• CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells.

  2012cited by this paper
• NF-κB and STAT3 – key players in liver inflammation and cancer

  2011cited by this paper
• Endothelial Cells Are Central Orchestrators of Cytokine Amplification during Influenza Virus Infection

  2011cited by this paper
• HCC and angiogenesis: possible targets and future directions

  2011cited by this paper
• Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function.

  2011cited by this paper
• Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism.

  2011cited by this paper
• ChemR23 Dampens Lung Inflammation and Enhances Anti-viral Immunity in a Mouse Model of Acute Viral Pneumonia

  2011cited by this paper
• Reduced expression of chemerin is associated with a poor prognosis and a lowed infiltration of both dendritic cells and natural killer cells in human hepatocellular carcinoma.

  2011cited by this paper
• HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment

  2010cited by this paper
• Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerin-induced endothelial angiogenesis.

  2010cited by this paper
• Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor

  2009cited by this paper
• Identification of Chemerin Receptor (ChemR23) in Human Endothelial Cells:

  2009cited by this paper
• Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment

  2009cited by this paper
• High serum interleukin‐6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B

  2009cited by this paper
• Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer 1

  2009cited by this paper
• Hierarchy of immunosuppressive strength among myeloid‐derived suppressor cell subsets is determined by GM‐CSF

  2009cited by this paper
• Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients.

  2009cited by this paper
• Myeloid-derived suppressor cells as regulators of the immune system

  2009cited by this paper
• Mast cell–expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis

  2008cited by this paper
• Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice1

  2008cited by this paper
• High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma.

  2008cited by this paper
• The genetic design of signaling cascades to record receptor activation

  2008cited by this paper
• A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.

  2008cited by this paper
• The role of myeloid cells in the promotion of tumour angiogenesis

  2008cited by this paper
• Chemerin, a Novel Adipokine That Regulates Adipogenesis and Adipocyte Metabolism*

  2007cited by this paper
• The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues.

  2007cited by this paper
• Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

  2007cited by this paper
• NF-κB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF

  2007cited by this paper
• Specific Recruitment of Antigen-presenting Cells by Chemerin, a Novel Processed Ligand from Human Inflammatory Fluids

  2003cited by this paper

• Exploring the Vasculitis‐Tumors Link: Epidemiological Patterns, Mechanistic Insights, and Clinical Implications

  2026cites this paper
• Triptolide impacts CSF1R expression andreprograms the suppressive function of myeloid-derived suppressor cells via targeting the ER stress pathway.

  2025cites this paper
• Chemerin and the Gut: From Inflammation to Cancer

  2025cites this paper
• Chemerin Exacerbates Pulmonary Inflammation in Type 2 Diabetes and Mycobacterium Tuberculosis Infection Comorbidity

  2025cites this paper
• Serum chemerin levels and the risk of muscle health decline in geriatric population

  2025cites this paper
• Immune-related adverse events in patients with low baseline serum IL-6 treated with durvalumab plus tremelimumab for hepatocellular carcinoma: a case series

  2025cites this paper
• Interactions in hepatic tumor microenvironment: Potential targets and modulations for effective therapy.

  2025cites this paper
• Active Forms of Chemerin Are Elevated in Human and Mouse Ovarian Carcinoma

  2025cites this paper
• The biological function and research progress of the adipokine chemerin in tumorigenesis and development

  2025cites this paper
• Nuclear translocation of metabolic enzyme PKM2 participates in high glucose-promoted HCC metastasis by strengthening immunosuppressive environment

  2024cites this paper
• Nomograms confirm serum IL-6 and CRP as predictors of immune checkpoint inhibitor efficacy in unresectable hepatocellular carcinoma

  2024cites this paper
• The Roles of Myeloid-Derived Suppressor Cells in Liver Disease

  2024cites this paper
• Exploring the role of adipokines in exercise-induced inhibition of tumor growth

  2024cites this paper
• Serum chemerin level in patients with liver cirrhosis and primary and multifocal hepatocellular carcinoma with consideration of insulin level

  2024cites this paper
• Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside

  2024cites this paper
• Serum interleukin‐6 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced hepatocellular carcinoma: a multicenter analysis

  2024cites this paper
• The chemerin-CMKLR1 axis in keratinocytes impairs innate host defense against cutaneous Staphylococcus aureus infection

  2024cites this paper
• Local administration of myeloid-derived suppressor cells prevents progression of immune-mediated dry eye disease.

  2024cites this paper
• Chemerin promotes invasion of oral squamous cell carcinoma by stimulating IL-6 and TNF-α production via STAT3 activation

  2024cites this paper
• Myeloid-Derived Suppressor Cells Promote Allograft Survival By Suppressing Treg Dysfunction in High-Risk Corneal Transplantation.

  2024cites this paper
• Prognostic stratification based on HIF-1α signaling for evaluating hypoxia status and immune landscape in hepatocellular carcinoma

  2023cites this paper
• Prognostic impact of chemerin expression in colorectal cancer: A detailed analysis based on histological components and meta-analysis.

  2023cites this paper
• Targeting intratumoral hypoxia to enhance anti-tumor immunity.

  2023cites this paper
• Unleashing the efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma: factors, strategies, and ongoing trials

  2023influential citation
• Exploring the regulatory role of lncRNA in cancer immunity

  2023cites this paper
• Progress in research on the role played by myeloid‐derived suppressor cells in liver diseases

  2023cites this paper
• Association of plasma chemerin with all-cause and disease-specific mortality – results from a population-based study

  2023cites this paper
• Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression

  2023cites this paper
• Obesity, obesities and gastrointestinal cancers.

  2023cites this paper
• IL-6 Levels Correlate with Prognosis and Immunosuppressive Stromal Cells in Patients with Colorectal Cancer

  2023cites this paper
• Cancer-cell-intrinsic mechanisms regulate MDSCs through cytokine networks.

  2023cites this paper
• Adipocyte-derived chemerin rescues lipid overload-induced cardiac dysfunction.

  2023cites this paper
• Correlation and efficacy of TACE combined with lenvatinib plus PD‐1 inhibitor in the treatment of hepatocellular carcinoma with portal vein tumor thrombus based on immunological features

  2023cites this paper
• Dense GM-CSFRα-expressing immune infiltration is allied with longer survival of intrahepatic cholangiocarcinoma patients

  2023cites this paper
• Chemerin and Chemokine-like Receptor 1 Expression Are Associated with Hepatocellular Carcinoma Progression in European Patients

  2023cites this paper
• Chemerin and Chemokine-like Receptor 1 Are Not Prognostic in Colorectal Carcinoma

  2023cites this paper
• Hotspots and Frontiers in Inflammatory Tumor Microenvironment Research: A Scientometric and Visualization Analysis

  2022cites this paper
• The role of Chemerin in human diseases.

  2022cites this paper
• Small extracellular vesicles as key players in cancer development caused by human oncogenic viruses

  2022influential citation
• Loss of Chemerin in Rhabdomyosarcoma Cells Polarizes Adjacent Monocytes to an Immunosuppressive Phenotype

  2022cites this paper
• The immunosuppressive tumor microenvironment in hepatocellular carcinoma-current situation and outlook.

  2022cites this paper
• Dissecting a hypoxia-related angiogenic gene signature for predicting prognosis and immune status in hepatocellular carcinoma

  2022cites this paper
• Epithelial chemerin–CMKLR1 signaling restricts microbiota-driven colonic neutrophilia and tumorigenesis by up-regulating lactoperoxidase

  2022cites this paper
• Interleukin-6 Is a Circulating Prognostic Biomarker for Hepatocellular Carcinoma Patients Treated with Combined Immunotherapy

  2022cites this paper
• Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinoma

  2022cites this paper
• GM-CSF: A Double-Edged Sword in Cancer Immunotherapy

  2022cites this paper
• G‐CSF/GM‐CSF‐induced hematopoietic dysregulation in the progression of solid tumors

  2022cites this paper
• Hepatocyte expressed chemerin-156 does not protect from experimental non-alcoholic steatohepatitis

  2022cites this paper
• Chemerin enhances mesenchymal features of glioblastoma by establishing autocrine and paracrine networks in a CMKLR1-dependent manner

  2022cites this paper
• The chemerin-CMKLR1 axis limits thermogenesis by controlling a beige adipocyte/IL-33/type 2 innate immunity circuit

  2021cites this paper
• Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages

  2021cites this paper
• Association between Inflammation and Function of Cell Adhesion Molecules Influence on Gastrointestinal Cancer Development

  2021cites this paper
• Chemerin located in bone marrow promotes osteogenic differentiation and bone formation via Akt/Gsk3β/β‐catenin axis in mice

  2021cites this paper
• Chemerin reverses the malignant phenotype and induces differentiation of human hepatoma SMMC7721 cells

  2021cites this paper
• Myeloid-Derived Suppressor Cells in Immune Microenvironment Promote Progression of Esophagogastric Junction Adenocarcinoma

  2021cites this paper
• In Situ Vaccination as a Strategy to Modulate the Immune Microenvironment of Hepatocellular Carcinoma

  2021cites this paper
• Promotion effects of DEHP on hepatocellular carcinoma models: up-regulation of PD-L1 by activating the JAK2/STAT3 pathway.

  2021cites this paper
• Revisiting Lung Cancer Metastasis: Insight From the Functions of Long Non-coding RNAs

  2021cites this paper
• Tumor NLRP3-Derived IL-1β Drives the IL-6/STAT3 Axis Resulting in Sustained MDSC-Mediated Immunosuppression

  2021cites this paper
• ALDH1A1 Activity in Tumor-Initiating Cells Remodels Myeloid-Derived Suppressor Cells to Promote Breast Cancer Progression

  2021cites this paper
• Therapeutic Values of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma: Facts and Hopes

  2021cites this paper
• Targeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and Challenges

  2021cites this paper
• A Chemerin Peptide Analog Stimulates Tumor Growth in Two Xenograft Mouse Models of Human Colorectal Carcinoma

  2021cites this paper
• Chronic stress promotes breast carcinoma metastasis by accumulating myeloid-derived suppressor cells through activating β-adrenergic signaling

  2021cites this paper
• Long Non-Coding RNAs (lncRNAs) in Response and Resistance to Cancer Immunosurveillance and Immunotherapy

  2021cites this paper
• The Concentration of CMKLR1 Expression on Clinicopathological Parameters of Colorectal Cancer: A Preliminary Study

  2021cites this paper
• Emerging Roles of Myeloid-Derived Suppressor Cells in Diabetes

  2021cites this paper
• PTGES/PGE2 signaling links immunosuppression and lung metastasis in Gprc5a-knockout mouse model

  2020cites this paper
• Ultrasound-mediated delivery of miRNA-122 and anti-miRNA-21 therapeutically immunomodulates murine hepatocellular carcinoma in vivo.

  2020cites this paper
• IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy.

  2020cites this paper
• Chemerin/CMKLR1 ameliorates nonalcoholic steatohepatitis by promoting autophagy and alleviating oxidative stress through the JAK2-STAT3 pathway.

  2020cites this paper
• Influence of tumor microenvironment on angiogenesis in hepatocellular carcinoma

  2020cites this paper
• Multidirectional Strategies for Targeted Delivery of Oncolytic Viruses by Tumor Infiltrating Immune Cells.

  2020cites this paper
• Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment.

  2020cites this paper
• Chemerin Is Induced in Non-Alcoholic Fatty Liver Disease and Hepatitis B-Related Hepatocellular Carcinoma

  2020influential citation
• Chemerin-156 is the Active Isoform in Human Hepatic Stellate Cells

  2020cites this paper
• Chemerin Isoform-Specific Effects on Hepatocyte Migration and Immune Cell Inflammation

  2020cites this paper
• TET2 promotes anti‐tumor immunity by governing G‐MDSCs and CD8+ T‐cell numbers

  2020cites this paper
• Circulating chemerin level and risk of cancer: a systematic review and meta-analysis.

  2020cites this paper
• Myeloid‐derived suppressor cells in obstetrical and gynecological diseases

  2020cites this paper
• Chemerin deficiency regulates adipogenesis is depot different through TIMP1

  2020cites this paper
• Chemerin Treatment Inhibits the Growth and Bone Invasion of Breast Cancer Cells

  2020cites this paper
• Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma

  2020cites this paper
• High-salt diet inhibits tumour growth in mice via regulating myeloid-derived suppressor cell differentiation

  2020cites this paper
• XIAOPI formula inhibits the pre-metastatic niche formation in breast cancer via suppressing TAMs/CXCL1 signaling

  2020cites this paper
• Systematic Review of the Roles of Interleukins in Hepatocellular Carcinoma.

  2020cites this paper
• Chemerin in immune response and gastrointestinal pathophysiology.

  2020cites this paper
• Overexpression of Hepatocyte Chemerin-156 Lowers Tumor Burden in a Murine Model of Diethylnitrosamine-Induced Hepatocellular Carcinoma

  2019cites this paper
• Hydrocortisone Suppresses Early Paraneoplastic In fl ammation And Angiogenesis To Attenuate Early Hepatocellular Carcinoma Progression In Rats

  2019cites this paper
• Hydrocortisone Suppresses Early Paraneoplastic Inflammation And Angiogenesis To Attenuate Early Hepatocellular Carcinoma Progression In Rats

  2019cites this paper
• A Detailed Insight of the Anti-inflammatory Effects of Curcumin with the Assessment of Parameters, Sources of ROS and Associated Mechanisms

  2019cites this paper
• More Than an Adipokine: The Complex Roles of Chemerin Signaling in Cancer

  2019influential citation
• Serum Chemerin Does Not Differentiate Colorectal Liver Metastases from Hepatocellular Carcinoma

  2019cites this paper
• Reactive Oxygen Species Are Involved in the Development of Gastric Cancer and Gastric Cancer-Related Depression through ABL1-Mediated Inflammation Signaling Pathway

  2019cites this paper
• Chemerin and Cancer

  2019cites this paper
• Chemerin partly mediates tumor‐inhibitory effect of all‐trans retinoic acid via CMKLR1‐dependent natural killer cell recruitment

  2019cites this paper
• Chemerin Suppresses Breast Cancer Growth by Recruiting Immune Effector Cells Into the Tumor Microenvironment

  2019cites this paper
• Chemerin Isoforms and Activity in Obesity

  2019cites this paper
• The serum biomarker chemerin promotes tumorigenesis and metastasis in oral squamous cell carcinoma.

  2019cites this paper
• Hydrocortisone Suppresses Early Paraneoplastic In fl ammation And Angiogenesis To Attenuate Early Hepatocellular Carcinoma Progression In Rats

  2019cites this paper